You have 9 free searches left this month | for more free features.

Patients with high risk adenocarcinoma of the prostate

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

Not yet recruiting
  • Prostate Adenocarcinoma
  • 68-Ga PSMA11
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 12, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Alkmaar, Netherlands
    • +27 more
    Jun 27, 2023

    Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)

    Terminated
    • Prostate Cancer
    • +2 more
    • Durham, North Carolina
      Duke University Medical Center
    Jun 3, 2022

    Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +6 more
    • (no location specified)
    Mar 28, 2023

    Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • Stage III Prostate Cancer
    • stereotactic body radiation therapy
    • +3 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Apr 28, 2022

    Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

    Recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • MRI-guided Intensity-Modulated Radiation Therapy
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 4, 2023

    Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

    Completed
    • Stage II Prostate Adenocarcinoma
    • Stage III Prostate Adenocarcinoma
    • Palo Alto, California
      Stanford University, School of Medicine
    Mar 2, 2022

    Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage

    Active, not recruiting
    • Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Dec 7, 2021

    Prostate Cancer, Prostatic Adenocarcinoma Trial in New York (degarelix injection, androgen deprivation therapy)

    Active, not recruiting
    • Prostate Cancer
    • Prostatic Adenocarcinoma
    • degarelix injection
    • androgen deprivation therapy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 28, 2022

    Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate

    Active, not recruiting
    • Adenocarcinoma of Prostate
    • Progression of Prostate Cancer
    • Villejuif, France
      Institut Gustave Roussy
    Oct 5, 2021

    Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)

    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiosurgical Boost
    • +2 more
    • Sacramento, California
      UC Davis Sacramento Cancer Center Dept of Radiation Oncology
    Sep 24, 2021

    Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

    Active, not recruiting
    • Prostate Adenocarcinoma
    • +5 more
    • Daratumumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)

    Withdrawn
    • Prostate Adenocarcinoma
    • MVA-BN-Brachyury
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Sep 21, 2021

    Prostate Cancer Trial in Jacksonville (< 15% risk of + LN, > 15% risk of + LN)

    Active, not recruiting
    • Prostate Cancer
    • < 15% risk of + LN
    • > 15% risk of + LN
    • Jacksonville, Florida
      University of Florida Proton Therapy Institute
    Dec 1, 2021

    Adenocarcinoma of the Prostate Trial in Jacksonville (HR-A, HR-B)

    Recruiting
    • Adenocarcinoma of the Prostate
    • HR-A
    • HR-B
    • Jacksonville, Florida
      University of Florida Health Proton Therapy Institute
    Mar 14, 2022

    Prostate Adenocarcinoma Trial in Park Ridge (CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation

    Recruiting
    • Prostate Adenocarcinoma
    • CyberKnife
    • +2 more
    • Park Ridge, Illinois
      Advocate Lutheran General Hospital
    Jul 19, 2021

    Prostate Adenocarcinoma, Radiation Toxicity Trial in Limassol (External beam radiation therapy, High-dose-rate brachytherapy,

    Recruiting
    • Prostate Adenocarcinoma
    • Radiation Toxicity
    • External beam radiation therapy, High-dose-rate brachytherapy
    • Goserelin 10.8 mg
    • Limassol, Cyprus
      German Oncology Center
    Aug 6, 2021

    Adenocarcinoma of the Prostate Trial in Dijon (Stereotactic Radiotherapy with Linac MRI)

    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiotherapy with Linac MRI
    • Dijon, France
      Centre Georges François Leclerc
    May 27, 2021

    Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

    Completed
    • Prostate Adenocarcinoma
    • +4 more
    • Abiraterone Acetate
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022